BioAtla and GATC Health Announce a $40 Million Special Purpose Vehicle (SPV) Transaction to Advance Ozuriftamab Vedotin (Oz-V) into a Registrational Trial for 2L+ Oropharyngeal ...

BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ OPSCC with the ...
PC Gamer

Risk of Rain 2 developer plans large 'expansions' and increased mod support

Hopoo Games revealed its post-launch plans in a weekend Steam update. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Risk of Rain 2 doesn't ...
Eurogamer

Risk of Rain 2 dev details post-launch content plans, including substantial paid expansions

Last month saw Hopoo Games' co-operative rogue-like shooter sequel Risk of Rain 2 get its full version 1.0 release on Steam following 18 months in early access, and, now, with that out the way and a ...
PC Gamer

Risk of Rain 2 is pushed back into August

It was supposed to be out this spring, but Hopoo Games wants to ensure the 1.0 release is 'a complete game experience.' When you purchase through links on our site, we may earn an affiliate commission ...
News Medical

Recombinant Protein Receptor Tyrosine Kinases ROR1 and ROR2

The ROR family of proteins includes ROR1 and ROR2 – receptor tyrosine kinases. ROR1 is especially interesting to pharmacologists as it has only been observed in cancerous and embryonic cells, and ...